Acute Intracerebroventricular Inositol Does Not Reverse the Effect of Chronic Lithium Treatment in the Forced Swim Test

Neuropsychobiology

Volumn 68, Issue 3, 2013, Pages 189-192

  Toker, L ^a,b   Kara, N ^a,b,c   Hadas, I ^b   Einat, H ^c   Bersudsky, Y ^b   Belmaker, R H ^b   Agam, G ^a,b  

^a Department of Clinical Biochemistry and Pharmacology ^*  (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c ACADEMIC COLLEGE OF TEL AVIV YAFFO   (Israel)

Author keywords

Forced swim test; Inositol; Lithium

Indexed keywords

INOSITOL; LITHIUM;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FORCED SWIM TEST; IMMOBILIZATION; LITHIUM BLOOD LEVEL; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL;

ANIMALS; BRAIN; DRUG INTERACTIONS; INJECTIONS, INTRAVENTRICULAR; INOSITOL; LITHIUM; MALE; MICE; MICE, INBRED ICR; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84886009548     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000355294     Document Type: Article

References (32)

1. Schloesser RJ, Martinowich K, Manji HK: Mood-stabilizing drugs: mechanisms of action. Trends Neurosci 2012; 35: 36-46.
2. Hallcher LM, Sherman WR: The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980; 255: 10896-10901.
3. Berridge MJ, Downes CP, Hanley MR: Neural and developmental actions of lithium: a unifying hypothesis. Cell 1989; 59: 411-419.
4. Klein PS, Melton DA: A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455-8459.
5. Stambolic V, Ruel L, Woodgett JR: Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996; 6: 1664-1668.
6. Diniz BS, Machado-Vieira R, Forlenza OV: Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat 2013; 9: 493-500.
7. Honchar MP, Olney JW, Sherman WR: Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science 1983; 220: 323-325.
8. Kofman O, Belmaker RH: Ziskind-Somerfeld research award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression. Biol Psychiatry 1993; 34: 839-852.
9. Evans MS, Zorumski CF, Clifford DB: Lithium enhances neuronal muscarinic excitation by presynaptic facilitation. Neuroscience 1990; 38: 457-468.
10. Belmaker RH, Bersudsky Y: Lithium-pilocarpine seizures as a model for lithium action in mania. Neurosci Biobehav Rev 2007; 31: 843-849.
11. O'Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S, Klein PS: Glycogen synthase kinase-3? haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 2004; 24: 6791-6798.
12. Bersudsky Y, Shaldubina A, Belmaker RH: Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss. Behav Pharmacol 2007; 18: 77-80.
13. Thurston JH, Sherman WR, Hauhart RE, Kloepper RF: Myo-inositol: a newly identified nonnitrogenous osmoregulatory molecule in mammalian brain. Pediatr Res 1989; 26: 482-485.
14. Belmaker RH, Agam G, van Calker D, Richards MH, Kofman O: Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients. Neuropsychopharmacology 1998; 19: 220-232.
15. Porsolt RD, Bertin A, Jalfre M: Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336.
16. Kofman O, Sherman WR, Katz V, Belmaker RH: Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures. Psychopharmacology (Berl) 1993; 110: 229-234.
17. Kofman O, Belmaker RH: Intracerebroventricular myo-inositol antagonizes lithium-induced suppression of rearing behaviour in rats. Brain Res 1990; 534: 345-347.
18. Shaltiel G, Dalton EC, Belmaker RH, Harwood AJ, Agam G: Specificity of mood stabilizer action on neuronal growth cones. Bipolar Disord 2007; 9: 281-289.
19. Williams RS, Cheng L, Mudge AW, Harwood AJ: A common mechanism of action for three mood-stabilizing drugs. Nature 2002; 417: 292-295.
20. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC: Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005; 170: 1101-1111.
21. Lubrich B, Patishi Y, Kofman O, Agam G, Berger M, Belmaker RH, van Calker D: Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus. Mol Psychiatry 1997; 2: 407-412.
22. O'Brien WT, Huang J, Buccafusca R, Garskof J, Valvezan AJ, Berry GT, Klein PS: Glycogen synthase kinase-3 is essential for arrestin-2 complex formation and lithium-sensitive behaviors in mice. J Clin Invest 2011; 121: 3756-3762.
23. Kim DH, Jung JS, Song DK, Suh HW, Huh SO, Kim YH: Intracerebroventricular injection-induced increase in plasma corticosterone levels in the mouse: a stress model. J Pharmacol Toxicol Methods 1998; 39: 71-73.
24. Herman ZS: Behavioural changes induced in conscious mice by intracerebroventricular injection of catecholamines, acetylcholine and 5-hydroxytryptamine. Br J Pharmacol 1975; 55: 351-358.
25. Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G: Treatment of bipolar depression: an update. J Affect Disord 2008; 109: 21-34.
26. Nixon MK, Hascoet M, Bourin M, Colombel MC: Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology (Berl) 1994; 115: 59-64.
27. Can A, Blackwell RA, Piantadosi SC, Dao DT, O'Donnell KC, Gould TD: Antidepressantlike responses to lithium in genetically diverse mouse strains. Genes Brain Behav 2011; 10: 434-443.
28. Can A, Piantadosi SC, Gould TD: Differential antidepressant-like response to lithium treatment between mouse strains: effects of sex, maternal care, and mixed genetic background. Psychopharmacology 2013; 17: 17.
29. Yadav R, Gupta SC, Hillman BG, Bhatt JM, Stairs DJ, Dravid SM: Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors. PLoS One 2012; 7:e32969.
30. Flaisher-Grinberg S, Einat H: A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior. J Pharmacol Toxicol Methods 2009; 59: 141-145.
31. Flaisher-Grinberg S, Einat H: Strain specific battery of tests for separate behavioral domains of mania. Front Psychiatry 2010; 1: 1-10.
32. Scotti MA, Lee G, Stevenson SA, Ostromecki AM, Wied TJ, Kula DJ, Gessay GM, Gammie SC: Behavioral and pharmacological assessment of a potential new mouse model for mania. Physiol Behav 2011; 103: 376-383.